Improving cardiometabolic trial execution: Key insight for sponsors
“Nothing can ruin your study faster than if your volunteers are not compliant and you can’t retain them.” This was…
“Nothing can ruin your study faster than if your volunteers are not compliant and you can’t retain them.” This was…
For emerging and mid-sized biopharma companies, selecting a drug development partner is now a strategic decision that can determine whether…
CinnaGen today announced that the European Medicines Agency (EMA) has adopted a positive opinion recommending the approval of Zandoriah® (teriparatide),…
As obesity reaches epidemic proportions worldwide, clinical trial teams face mounting pressure to demonstrate meaningful health benefits beyond weight loss…
Congratulations on the Site Innovation award—what core R&D site problem did you target first, and how has that challenge changed…
The J. P. Morgan Healthcare Conference 2026 (JPM 2026) offers an early view of investor sentiment in the healthcare industry…
Key insights include: Precision oncology advances driving radiopharmaceutical innovation and adoption. Rising global trial activity and early-phase development. Strong market…
Improving and accelerating electronic data capture (EDC) setup times in clinical trials can deliver tangible results and valuable efficiencies. …
Induced pluripotent stem cells (iPSCs) offer immense medical potential1. With almost unrivalled levels of versatility, iPSCs can be modified into…
Pregnancy safety evaluation has become a critical focus in the post-marketing phase of drug development, largely because pregnant women are…